BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 7610990)

  • 1. Mediation of inflammation by cyclooxygenase-2.
    Seibert K; Masferrer J; Zhang Y; Gregory S; Olson G; Hauser S; Leahy K; Perkins W; Isakson P
    Agents Actions Suppl; 1995; 46():41-50. PubMed ID: 7610990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of COX-1 and COX-2 in normal and inflamed tissues.
    Seibert K; Zhang Y; Leahy K; Hauser S; Masferrer J; Isakson P
    Adv Exp Med Biol; 1997; 400A():167-70. PubMed ID: 9547553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New NSAIDs and gastroduodenal damage.
    Folco GC
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
    Flower RJ
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.
    Seibert K; Zhang Y; Leahy K; Hauser S; Masferrer J; Perkins W; Lee L; Isakson P
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12013-7. PubMed ID: 7991575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-steroidal antiinflammatory drug--management of gastrointestinal complications and inhibition of COX-2].
    Tada Y; Nagasawa K
    Nihon Rinsho; 1999 Feb; 57(2):419-24. PubMed ID: 10078017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase isoforms and atherosclerosis.
    Belton O; Fitzgerald DJ
    Expert Rev Mol Med; 2003 Mar; 5(9):1-18. PubMed ID: 14987412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inducible cyclooxygenase (COX-2) in inflammation.
    Seibert K; Masferrer JL
    Receptor; 1994; 4(1):17-23. PubMed ID: 8038702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2: a therapeutic target.
    Turini ME; DuBois RN
    Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of cyclooxygenase-1 in inflammation.
    Smith CJ; Zhang Y; Koboldt CM; Muhammad J; Zweifel BS; Shaffer A; Talley JJ; Masferrer JL; Seibert K; Isakson PC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13313-8. PubMed ID: 9789085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances].
    Hinz B; Brune K
    Wien Klin Wochenschr; 1999 Feb; 111(3):103-12. PubMed ID: 10093892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications.
    Pairet M; Engelhardt G
    Fundam Clin Pharmacol; 1996; 10(1):1-17. PubMed ID: 8900495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of antiinflammatory drugs.
    Vane JR; Botting RM
    Int J Tissue React; 1998; 20(1):3-15. PubMed ID: 9561441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.